Local MicroRNA Modulation Using a Novel Anti-miR-21–Eluting Stent Effectively Prevents Experimental In-Stent Restenosis
Author(s) -
Dong Wang,
T. Deuse,
Mandy Stubbendorff,
Ekaterina Chernogubova,
Reinhold G. Erben,
Suzanne M. Eken,
Hong Jin,
Yuhuang Li,
Albert Busch,
ChristianHendrik Heeger,
Boris Behnisch,
Hermann Reichenspurner,
Robert C. Robbins,
Joshua M. Spin,
Philip S. Tsao,
Sonja Schrepfer,
Lars Mäegdefessel
Publication year - 2015
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.115.305597
Subject(s) - restenosis , microrna , stent , medicine , cardiology , cancer research , modulation (music) , chemistry , biochemistry , gene , philosophy , aesthetics
Despite advances in stent technology for vascular interventions, in-stent restenosis (ISR) because of myointimal hyperplasia remains a major complication.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom